FdaApplication

BLA 761202

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSamsung Bioepis Co., Ltd.
application_typeBLA
approval_date2021-09-17

Products (2)

ProductActive ingredientStrengthDosage form
BYOOVIZRANIBIZUMAB-NUNA10MG/ML (0.5MG/0.05ML)Injection
BYOOVIZ—10MG/ML (0.5MG/0.05ML)Injection

2 products